Author:
Drabina Pavel,Feixová Viola,Sedlák Miloš
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Reference24 articles.
1. Selective Factor Xa Inhibition Improves Efficacy of Venous Thromboembolism Prophylaxis in Orthopedic Surgery
2. Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor
3. Highlights of Prescribing Information of XARELTO, Rivaroxaban, Extended-Release Tablets. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202439s001lbl.pdf Accessed 2011.
4. Facile approach for the synthesis of rivaroxaban using alternate synthon: reaction, crystallization and isolation in single pot to achieve desired yield, quality and crystal form
5. A. Straub, T. Lampe, J. Pohlmann, S. Röhrig, E. Perzborn, K.-H. Schlemmer, J. Pernerstorfer, WO 0147919 A9 (2001).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献